"High Grade Neuroendocrine Neoplasms & Small Cell Lung Cancer" • LACNETS Event • May 7, 2024

"High Grade Neuroendocrine Neoplasms & Small Cell Lung Cancer" • LACNETS Event • May 7, 2024Подробнее

"Large Cell Neuroendocrine Carcinoma & Small Cell Lung Cancer" • Session B • LACNETS • Dec 10, 2024Подробнее

Live Webinar with Dr. Edward Wolin "Advances in Neuroendocrine Tumor Therapy"Подробнее

LACNETS Webinar: "Update on Lung NETs" with Dr. Sukhmani PaddaПодробнее

(3) "NETs: How We Find, Classify, & Treat Them:" Dr. Phan - LACNETS CFCF 2015 NET ConferenceПодробнее

LACNETS • "High Grade Neuroendocrine Neoplasms (NEN)" with Dr. Jason Starr • May 2023Подробнее

Patient Story - Living with High Grade Neuroendocrine CancerПодробнее

LACNETS Webinar - "Updates in High Grade Neuroendocrine Tumors" with Dr. Aman ChauhanПодробнее

LACNETS Webinar: "Advances in Neuroendocrine Tumor Therapy" with Dr. Edward WolinПодробнее

Dr. Patel on Benefit of Ipilimumab/Nivolumab Combo in High-Grade Neuroendocrine CarcinomaПодробнее

"Understanding the Latest NET Clinical Trials" Dr. Pamela Kunz • 2024 #LACNETS Patient ConferenceПодробнее

Dr. Reidy Lagunes on the Potential of Immunotherapy in NETsПодробнее

Irinotecan/cisplatin vs etoposide/cisplatin in resected high-grade neuroendocrine lung carcinomaПодробнее

DAREON™-9: DLL-3 BiTE + Topotecan in Small Cell Lung Cancer (SCLC) • Dr. Aman ChauhanПодробнее

"TKIs: Tyrosine Kinase Inhibitors & Neuroendocrine Tumors" • 2024 LACNETS Event • March 29, 2024Подробнее

High Grade Neuroendocrine CarcinomasПодробнее

2024 LACNETS Conference Closing • Co-Moderators & the LACNETS TeamПодробнее

Dr. Patel on Benefit of Ipilimumab/Nivolumab Combo in High-Grade Neuroendocrine CarcinomaПодробнее

Welcome and Introductions • 2024 #LACNETS Neuroendocrine Tumor Patient ConferenceПодробнее